Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Portal   Teaching

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA


  • The Atlas of Genetics and Cytogenetics in Oncology and Haematology is a peer reviewed on-line journal, encyclopaedia and database in free access on the Internet, devoted to genes, cytogenetics, and clinical entities in cancer, and cancer-prone diseases.
  • The aim is to cover the entire field under study: as the task is huge, the Atlas is -and will be- incomplete by that very fact.

  • It presents structured reviews (cards) or traditional review papers ('deep insights'), a portal towards genetics and/or cancer databases and journals, teaching items in Genetics for students in Medicine and in Sciences, and a case report in hematology section.
  • It deals with cancer research and genomics. It is at the crossroads of research, virtual medical university (university and post-university e-learning), and telemedicine. It contributes to "meta-medicine", this mediation, using new information technology, between the increasing amount of knowledge and the individual, having to use the information. Toward a personalized medicine of cancer.
  • It is made for and by: clinicians and researchers in cytogenetics, molecular biology, oncology, haematology, and pathology. Contributions are reviewed before acceptance by members of the Editorial Board.

  • The Atlas is in open free access for readers, and there are no fees for the authors (the opposite of "predatory open access publishing").
  • The Atlas is a not-for-profit organization and each member is benevolent/volunteer.
  • It relies on individual donations, grants (scientific societies, charities), working hours for staff of research, higher education and health care public institutions (see Activity reports ).

    The Atlas is a collaborative effort!

    Historical Survey

    In 1997, Jean Loup Huret has created the Atlas (someone said "the Wikipedia of Cancer Genetics before Wikipedia"), with Philippe Dessen as the Database Director, who built and maintains the database.

    The Atlas contains nearly 3,000 papers and 10,000 pages, written by more than 3,500 authors (see and ). The Atlas is made of 45,000 pages, including "automatic" pages generated by computer programs (e.g. "Non-annotated" genes) with Philippe Dessen's expertise) with an iconography of about 35,000 images, 40,000 internal links and 730,000 external links. Printed, it would be about 200,000 pages, with 5,500 unique visitors every day. The "Scientific Journal" version of the Atlas (see ) is indexed in Scopus/Embase, and, in many countries, it is of significant value for your young collaborators to have papers indexed in Scopus. Next step would/should be PubMed.

    The Atlas combines different types of knowledge: genes and their function, cell biology, pathological data, diseases and their clinical implications, cytogenetics, but also medical genetics, with hereditary disorders associated with an increased risk of cancer. This gives a wider and more global view of cancer genetics, while these data are usually dispersed. The Atlas is the only genetic site where the prognosis is included. Dan van Dyke said "This is one stop shopping that unifies cancer genetics information", and Lidia Larizza said that the Atlas was an "interdisciplinary resource". Felix Mitelman said "This systematic collection of cytogenetic and genetic aberrations (…) the molecular outcome (…) and the clinical consequences (….) has grown into a truly monumental encyclopedic work of great importance"; Janet Rowley said: "In the future I will undoubtedly rely on your Website rather than trying to keep up with the literature myself" (more at ). It is an original/unique database without equivalent.

    In 2018, Jean Loup Huret asked Jesús María Hernández Rivas (Salamanca, Spain) and Paola Dal Cin (Boston, Massachusetts) to become Co-Editors in Chief, Jesús being in charge of the Hematology, and Paola in charge of Solid Tumors, Jean Loup Huret remaining the Editor in Chief for the field of Genes/Cell Biology/Cancer-prone diseases.
    The Atlas database will move soon to Salamanca, and be renewed, Ana Rodríguez (Salamanca) being the coordinator (provisional address: ).
    As on the first of April, 2021 Alessandro Beghini (Milano, Italy) and João Agostinho Machado-Neto (São Paulo, Brazil) have very kindly accepted to replace Jean Loup Huret. They will be the Editors in Chief in charge of Genes/Cell Biology/Cancer-prone diseases.

    After 25 years building the Atlas day after day, Jean Loup Huret and Philippe Dessen will take a little rest and wish long life to the Atlas and to the whole community of clinicians and researchers.

    Editorial Board

    Emeritus Editor-in-Chief (1997-2021)  Jean-Loup Huret (Poitiers, France)
    Editors-in-Chief  Jesús María Hernández Rivas (Salamanca, Spain) HEMATOLOGY
    Paola Dal Cin (Boston, Massachusetts) SOLID TUMORS
    Alessandro Beghini (Milano, Italy) GENES/CELL BIOL.
    João Agostinho Machado-Neto (São Paulo, Brazil) GENES/CELL BIOL.
    Database Director Philippe Dessen (Villejuif, France)
    Salamanca Coordinator Ana E. Rodríguez (Salamanca, Spain)

    Urinary Tumors Section Editor
    Soft Tissue Section Editor

      Paola Dal Cin (Boston, Massachusetts)
    Hematology Section Editors Teresa Gonzalez (Salamanca, Spain)
    Bone Tumors Section Editor Judith Bovee (Leiden, The Netherlands)
    Pediatric Tumors Section Editor Frederic G. Barr (Bethesda, Maryland)
    Cancer Prone Diseases Section Editor Gaia Roversi (Milano, Italy)
    B-cell activation Section Editors  Anette Gjörloff Wingren and Barnabas Nyesiga (Malmö, Sweden)
    Cell Cycle Section Editor João Agostinho Machado-Neto (São Paulo, Brazil)
    DNA Repair Section Editor Godefridus Peters (Amsterdam, The Netherlands)
    Epigenetics Section Editor Roberto Piergentili (Rome, Italy)
    Hematopoeisis Section Editor Olga Weinberg (Boston, Massachusetts)
    Hormones and Growth factors Section Editor Gajanan V. Sherbet (Newcastle upon Tyne, UK)
    Mitosis Section Editor Patrizia Lavia (Rome, Italy)
    Oxidative stress Section Editor Thierry Soussi (Stockholm, Sweden/Paris, France)
    WNT pathway Section Editor Alessandro Beghini (Milano, Italy)


    Data Management until March 2015:  Mohammad Ahmad, Mélanie Arsaban, Vanessa Le Berre, Anne Malo, Carol Moreau.
    Board Members
    Sreeparna Banerjee   Department of Biological Sciences, Middle East Technical University, Ankara, Turkey;
    Alessandro Beghini   Department of Health Sciences, University of Milan, Italy;
    Judith Bovée   2300 RC Leiden, The Netherlands;
    Antonio Cuneo   Dipartimento di Scienze Mediche, Sezione di Ematologia e Reumatologia Via Aldo Moro 8, 44124 - Ferrara, Italy;
    Paola Dal Cin   Department of Pathology, Brigham, Women's Hospital, 75 Francis Street, Boston, MA 02115, USA;
    François Desangles   IRBA, Departement Effets Biologiques des Rayonnements, Laboratoire de Dosimetrie Biologique des Irradiations, Dewoitine C212, 91223 Bretigny-sur-Orge, France;
    Enric Domingo   Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, Roosevelt Dr. Oxford, OX3 7BN, UK
    Ayse Elif Erson-Bensan   Department of Biological Sciences, Middle East Technical University, Ankara, Turkey;
    Ad Geurts van Kessel   Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, 6500 HB Nijmegen, The Netherlands;
    Oskar A. Haas   Department of Pediatrics and Adolescent Medicine, St. Anna Children's Hospital, Medical University Vienna, Children's Cancer Research Institute Vienna, Vienna, Austria.
    Anne Hagemeijer   Center for Human Genetics, University Hospital Leuven and KU Leuven, Leuven, Belgium;
    Nyla Heerema   Department of Pathology, The Ohio State University, 129 Hamilton Hall, 1645 Neil Ave, Columbus, OH 43210, USA;
    Sakari Knuutila   Hartmann Institute and HUSLab, University of Helsinki, Department of Pathology, Helsinki, Finland;
    Lidia Larizza   Lab Centro di Ricerche e Tecnologie Biomediche IRCCS-Istituto Auxologico Italiano Milano, Italy; l.larizza@auxologico
    Roderick McLeod   Department of Human, Animal Cell Lines, Leibniz-Institute DSMZ-German Collection of Microorganisms, Cell Cultures, Braunschweig, Germany;
    Cristina Mecucci   Hematology University of Perugia, University Hospital S.Maria della Misericordia, Perugia, Italy;
    Fredrik Mertens   Department of Clinical Genetics, University and Regional Laboratories, Lund University, SE-221 85 Lund, Sweden;
    Konstantin Miller   Institute of Human Genetics, Hannover Medical School, 30623 Hannover, Germany;
    Felix Mitelman   Department of Clinical Genetics, University and Regional Laboratories, Lund University, SE-221 85 Lund, Sweden;
    Hossain Mossafa   Laboratoire CERBA, 95066 Cergy-Pontoise cedex 9, France;
    Stefan Nagel   Department of Human, Animal Cell Lines, Leibniz-Institute DSMZ-German Collection of Microorganisms, Cell Cultures, Braunschweig, Germany;
    Florence Pedeutour   Laboratory of Solid Tumors Genetics, Nice University Hospital, CNRS UMR 7284/INSERM U1081, France;
    Susana Raimondi   Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Mail Stop 250, Memphis, Tennessee 38105-3678, USA;
    Clelia Tiziana Storlazzi   Department of Biology, University of Bari, Bari, Italy;
    Sabine Strehl   CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung e.V., Vienna, Austria;
    Nancy Uhrhammer   Laboratoire Diagnostic Génétique et Moléculaire, Centre Jean Perrin, Clermont-Ferrand, France;
    Dan L. Van Dyke   Mayo Clinic Cytogenetics Laboratory, 200 First St SW, Rochester MN 55905, USA;
    Roberta Vanni   Universita di Cagliari, Dipartimento di Scienze Biomediche(DiSB), Cittadella Universitaria, 09042 Monserrato (CA) - Italy;
    Franck Viguié   Service d'Histologie-Embryologie-Cytogénétique, Unité de Cytogénétique Onco-Hématologique, Hôpital Universitaire Necker-Enfants Malades, 75015 Paris, France;

    Past Board Members
    Anne von Bergh   Afdeling Klinische Genetica, Erasmus MC, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands;
    Vasantha Brito-Babapulle   Section of Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UK;
    Charles Buys   Department of Genetics, University Medical Center Groningen, Groningen, the Netherlands;
    Anne Marie Capodano   Laboratoire de Cytogénétique Oncologique, Hôpital de la Timone, 264 rue Saint Pierre, 13005 Marseille, France;
    Fei Chen  

    Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, USA;

    Louis Dallaire   Centre de Recherche, Hôpital Ste-Justine, Montréal, Canada
    Brigitte Debuire   Service de Biochimie et Biologie moléculaire, Hôpital Paul Brousse, Faculté de Medecine Paris Sud, 94 800 Villejuif, France;
    Gordon Dewald   Cytogenetics, Division of Laboratory Genetics, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA;
    Richard Gatti   David Geffen School of Medicine at UCLA, Los Angeles Department of Pathology & Laboratory Medicine, 675 Charles Young Dr South, MRL 4-736, Los Angeles, CA 90095, USA;
    Jim Heighway   Cancer Communications and Consultancy Ltd, Knutsford, Cheshire, UK;
    Lisa Lee-Jones   Tumour Molecular Genetics Group, Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff, CF14 4XN, UK;
    Edmond Ma   Department of Pathology, Hong Kong Sanatorium and Hospital , Happy Valley, Hong Kong , China;
    Elizabeth Petty   University of Wisconsin School of Medicine, Public Health, Madison, WI 53705-2221, USA;
    Mariano Rocchi   Department of Biology, University of Bari, Bari, Italy.
    Alain Sarasin   Service de génétique, Département de biopathologie, CLCC Institut Gustave Roussy, 94805 Villejuif, France;
    Albert Schinzel   Institute of Medical Genetics, University of Zurich, Zurich, Switzerland;
    José Luis Vizmanos   Departamento de Bioquímica y Genética, Universidad de Navarra. Campus Universitario. 31009 Pamplona, Spain;
    Thomas Wan   Haematology Division, Department of Anatomical & Cellular Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China;


    List of Authors A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  


    Jean-Loup HURET, Genetics, Dept Medical Information,
    University Hospital, F-86021 Poitiers, FRANCE.
    tel +33 5 49 44 45 46 or +33 5 49 45 47 67 or

    See Editor, Editorial Board and Publisher

    Rules, Copyright Notice and Disclaimer

    Advertising policy
    The site does not display advertisements, and does not host or receive funding from advertising or from the display of commercial content.
    Corporate patronage is welcome.

    Editorial policies
    You will find additional publications policies and requirements applied in the Atlas at the site of the International Committee of Medical Journal Editors: Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication - Updated October 2004

    Creative Commons License   This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License.

    As cards are to evolve with further improvements and updates from various contributors, the property of the cards belongs to the editor, and modifications will be made without authorization from the previous contributor (who may, nonetheless, be asked for refereeing); contributors are listed in an edit history manner. Nonetheless, contributors keep the rights to use further the content of their papers published in the Atlas, provided that the source is cited.

    The information in the Atlas of Genetics and Cytogenetics in Oncology and Haematology is issued for general distribution. All rights are reserved. The information presented is protected under international conventions and under national laws on copyright and neighboring rights. Commercial use is totally forbidden. Information extracted from the Atlas may be reviewed, reproduced or translated for research or private study but not for sale or for use in conjunction with commercial purposes. Any use of information from this web site should be accompanied by an acknowledgment of the Atlas as the source, citing the uniform resource locator (URL) of the article. Reference to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement, recommendation, or favoring. The views and opinions of contributors and authors expressed herein do not necessarily state or reflect those of the Atlas editorial staff or of the web site holder, and shall not be used for advertising or product endorsement purposes. The Atlas does not makes any warranty, express or implied, including the warranties of merchantability and fitness for a particular purpose, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, and shall not be liable whatsoever for any damages incurred as a result of its use. In particular, information presented in the Atlas is only for research purpose, and shall not be used for diagnosis or treatment purposes. No responsability is assumed for any injury and/or damage to persons or property for any use or operation of any methods products, instructions or ideas contained in the material herein.

    Guidelines for Citing the Atlas

    1- Citation for the whole project

    - Atlas of genetics and cytogenetics in oncology and haematology in 2013.
    Huret JL, Ahmad M, Arsaban M, Bernheim A, Cigna J, Desangles F, Guignard JC, Jacquemot-Perbal MC, Labarussias M, Leberre V, Malo A, Morel-Pair C, Mossafa H, Potier JC, Texier G, Viguié F, Yau Chun Wan-Senon S, Zasadzinski A, Dessen P.
    Nucleic Acids Res. 2013 Jan;41(Database issue):D920-4.

    - An internet database on genetics in oncology
    Huret JL, Dessen P, Bernheim A.
    Oncogene 2003; 22: 1907.

    - Lifelines: browsing the cancer catalogue.
    Pearson H.
    Nature Science Updates 31/5/2001.

    - Fingerprinting a killer.
    Kaiser J.
    Science 8 June 2001; Vol 292: 1803.

    2- Citation in general
    Atlas of Genetics and Cytogenetics in Oncology and Haematology. URL


    Main Past Grants
    European Regional Development Fund, Ministry of Research, Ministry of Social Affairs, National League against Cancer, National Cancer Institute (France).

    The Atlas benefits from the resources of INIST-CNRS.

    Note: We would like to thank Nicole E. McNeil (Bethesda), Béatrice Fernandez, Nathalie Quellard, and Serge Milin (Poitiers), Marie-Aline Dodin (Prissé La Charrière), and Hossain Mossafa (Paris) for permission their iconography for logos in the Atlas.


    X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

    Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Portal   Teaching

    Last update : Thu Feb 15 10:33:31 CET 2018